Mr. Carcillo’s keynote, “From Advocate to Executive: How my patient experience influences my work as CEO,” will cover his personal experience with psychedelic treatments and the inspiration that led him to found and lead Wesana. He will explore how he transformed himself from patient to advocate, to an inspiring leader.
- Mr. Carcillo’s talk will begin at
9:10AM Pacific time onThursday, June 9, 2022 - Immediately following his keynote,
Mateusz Dudek , PhD ofCharles River will present “Reverse Engineering Discovery: A Collaborative Pathway to Preclinical Assessment ofDaniel Carcillo's Experience”
Event Overview
The mental health epidemic, including substance use and addiction, is a global issue. The crises began long before the COVID-19 pandemic, but two years of work? loss, stress, isolation, and treatment disruption has only exacerbated the number of people struggling with their mental health. Innovations in the range of medicines currently used in conjunction with psychotherapy have had little to no progress over the last two decades. The use of psychedelic therapy has changed this paradigm. With increased preclinical research and clinical trials illustrating the beneficial effects of first-generation psychedelics, a wave of second-generation therapeutics is now emerging. This event will highlight progress in both areas of translational research and provide a panel discussion on the trials and tribulations of developing these therapies for commercialization. To attend this hybrid event virtually or in person, visit: https://bit.ly/3tZuibl
About
Wesana Health helps people transcend barriers in mental health and performance. We innovate in care development through our therapies and patent-pending protocols, and in care delivery through activating a new multidisciplinary, technology-supported clinical model. Learn more at www.wesanahealth.com.
Investor Relations:
Email: IR@wesanahealth.com
Phone: 702-329-8038
Media Contacts:
Email: media@wesanahealth.com
Phone: 917-653-4613
Source:
2022 GlobeNewswire, Inc., source